Agomab Therapeutics NV (AGMB) at a glance

Agomab Therapeutics NV (AGMB) is a small-cap Healthcare company. It trades at $13.09, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (62/100) and its weakest is Income (40/100).

Price
$13.09
Market cap
$473.3M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$8.75 to $17.82
Vestovix Score50/ 100How this works
Value
50
Growth
50
Income
40
Safety
62
Momentum
48

Other Healthcare stocks

See all